Function after organ preservation after neoadjuvant therapy of rectal cancer

[1] Bryant C.L., Lunniss P.J., Knowles C.H., Thaha M.A., Chan C.L., Anterior resection syndrome, Lancet Oncol., 13, pp. e403-e408, (2012)

[2] Juul T., Ahlberg M., Biondo S., Espin E., Jimenez L.M., Matzel K.E., Palmer G.J., Sauermann A., Trenti L., Zhang W., Laurberg S., Christensen P., Low anterior resection syndrome and quality of life: an international multicenter study, Dis. Colon Rectum, 57, pp. 585-591, (2014)

[3] Bregendahl S., Emmertsen K.J., Lous J., Et al., Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study, Colorectal Dis, 15, pp. 1130-1139, (2013)

[4] Hoerske C., Weber K., Goehl J., Et al., Long-term outcomes and quality of life after rectal carcinoma surgery, Br J Surg, 97, pp. 1295-1303, (2010)

[5] Bondeven P., Emmertsen K.J., Laurberg S., Et al., Neoadjuvant therapy abolishes the functional benefits of a larger rectal remnant, as measured by magnetic resonance imaging after restorative rectal cancer surgery, Eur J Surg Oncol, 41, pp. 1493-1499, (2015)

[6] Appelt A.L., Ploen J., Harling H., Et al., High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study, Lancet Oncol., 16, pp. 919-927, (2015)

[7] Guillem J.G., Chessin D.B., Shia J., Et al., Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point, J. Clin. Oncol., 23, pp. 3475-3479, (2005)

[8] Smith F.M., Wiland H., Mace A., Et al., Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy, Dis Colon Rectum, 57, pp. 311-315, (2014)

[9] Hiotis S.P., Weber S.M., Cohen A.M., Et al., Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients, J. Am. Coll. Surg., 194, pp. 131-135, (2002)

[10] Garcia-Aguilar J., Shi Q., Thomas C.R., Et al., A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial, Ann. Surg. Oncol., 19, pp. 384-391, (2012)

[1] Bryant C.L., Lunniss P.J., Knowles C.H., Thaha M.A., Chan C.L., Anterior resection syndrome, Lancet Oncol., 13, pp. e403-e408, (2012)

[2] Juul T., Ahlberg M., Biondo S., Espin E., Jimenez L.M., Matzel K.E., Palmer G.J., Sauermann A., Trenti L., Zhang W., Laurberg S., Christensen P., Low anterior resection syndrome and quality of life: an international multicenter study, Dis. Colon Rectum, 57, pp. 585-591, (2014)

[3] Bregendahl S., Emmertsen K.J., Lous J., Et al., Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study, Colorectal Dis, 15, pp. 1130-1139, (2013)

[4] Hoerske C., Weber K., Goehl J., Et al., Long-term outcomes and quality of life after rectal carcinoma surgery, Br J Surg, 97, pp. 1295-1303, (2010)

[5] Bondeven P., Emmertsen K.J., Laurberg S., Et al., Neoadjuvant therapy abolishes the functional benefits of a larger rectal remnant, as measured by magnetic resonance imaging after restorative rectal cancer surgery, Eur J Surg Oncol, 41, pp. 1493-1499, (2015)

[6] Appelt A.L., Ploen J., Harling H., Et al., High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study, Lancet Oncol., 16, pp. 919-927, (2015)

[7] Guillem J.G., Chessin D.B., Shia J., Et al., Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point, J. Clin. Oncol., 23, pp. 3475-3479, (2005)

[8] Smith F.M., Wiland H., Mace A., Et al., Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy, Dis Colon Rectum, 57, pp. 311-315, (2014)

[9] Hiotis S.P., Weber S.M., Cohen A.M., Et al., Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients, J. Am. Coll. Surg., 194, pp. 131-135, (2002)

[10] Garcia-Aguilar J., Shi Q., Thomas C.R., Et al., A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial, Ann. Surg. Oncol., 19, pp. 384-391, (2012)